Medicine Description actilyse 20mg
Actilyse 20mg Ampoules is a medication that acts as a tissue plasminogen activator (tPA). It works by converting plasminogen, a precursor protein found in the blood, into plasmin, an enzyme that breaks down fibrin, a key component of blood clots. By facilitating the breakdown of fibrin, alteplase effectively dissolves existing blood clots that obstruct blood flow in various vascular regions, thereby restoring circulation. This mechanism is particularly crucial in acute medical conditions such as ischemic stroke, where timely intervention can significantly reduce cerebral damage and improve patient outcomes. The administration of Actilyse should be carefully timed to maximize efficacy and minimize risks associated with bleeding complications.
Indications and Uses of Actilyse 20mg Ampoules
- Acute ischemic stroke: To dissolve blood clots that block blood flow to the brain, ideally administered within a specified timeframe after symptom onset.
- Pulmonary embolism: Used to treat blood clots that obstruct the pulmonary artery, enhancing blood flow to the lungs.
- Acute myocardial infarction: To restore blood flow to the heart muscle in the event of a heart attack, thereby minimizing cardiac damage.
Side Effects of Actilyse 20mg Ampoules
- Bleeding complications: Increased risk of hemorrhage, which may occur internally or externally.
- Allergic reactions: Potential for hypersensitivity that may manifest as itching, rash, or more severe anaphylactic reactions.
- Hypotension: A drop in blood pressure may occur, particularly during the infusion.
- Arrhythmias: Potential for irregular heartbeats during or after treatment.
Storage and Handling
Actilyse 20mg Ampoules should be stored in a refrigerator at a temperature between 2°C to 8°C. Protect from light and avoid freezing. The medication should not be used after the expiration date and should be discarded if any visible particulates are present.
Patient Advice and Precautions
Patients receiving Actilyse should be closely monitored for signs of bleeding and other adverse effects during treatment. It is essential to inform healthcare professionals of any recent surgeries, bleeding disorders, or medications that may increase the risk of bleeding. Adherence to treatment protocols and timing is critical for maximizing the benefits of therapy while minimizing complications.